Results 241 to 250 of about 71,273 (273)
Cellular immunotherapies for central nervous system cancers. [PDF]
Neurooncol AdvScott BJ, Monje M.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Treatment Options in Neurology, 2012
The mainstay of medulloblastoma treatment is high-quality interdisciplinary collaboration in diagnosis, treatment, and aftercare by all involved disciplines. The first step in treatment of medulloblastoma is a maximal safe surgery, followed by thorough staging.
von Hoff, Katja, Rutkowski, Stefan
+6 more sources
The mainstay of medulloblastoma treatment is high-quality interdisciplinary collaboration in diagnosis, treatment, and aftercare by all involved disciplines. The first step in treatment of medulloblastoma is a maximal safe surgery, followed by thorough staging.
von Hoff, Katja, Rutkowski, Stefan
+6 more sources
min - Minimally Invasive Neurosurgery, 1993
81 patients with biopsy proven medulloblastoma with a mean age of 11.4 years were reviewed. Total removal of the tumour was accomplished in 18 cases (22.2%), subtotal removal in 55 cases (67.9%) and biopsy alone in 8 cases (9.9%). 34 patients (27.5%) had a recurrence of the tumour and 8 patients underwent a second posterior fossa exploration at the ...
H Z, Gökalp +5 more
openaire +2 more sources
81 patients with biopsy proven medulloblastoma with a mean age of 11.4 years were reviewed. Total removal of the tumour was accomplished in 18 cases (22.2%), subtotal removal in 55 cases (67.9%) and biopsy alone in 8 cases (9.9%). 34 patients (27.5%) had a recurrence of the tumour and 8 patients underwent a second posterior fossa exploration at the ...
H Z, Gökalp +5 more
openaire +2 more sources